{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-105037","form_type":"8-K","ticker":"KRRO","cik":"0001703647","company_name":"Korro Bio, Inc.","filed_at":"2024-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.664928+00:00","generated_at":"2026-06-03T14:09:20.104688+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Korro Bio closes $70M private placement to fund Phase 1/2 trial of KRRO-110","bullets":["Sold 1,249,283 shares at $56.00 per share for gross proceeds of ~$70M.","Led by Deep Track Capital; includes Atlas Venture, Blue Owl, NEA, Rock Springs, Tri Locum.","Proceeds plus existing $166.4M cash to fund Phase 1/2 trial of KRRO-110 in AATD through 2026.","Piper Sandler, RBC Capital, BMO Capital Markets acted as placement agents."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-105037","json":"https://secwatch.observer/filing/0001193125-24-105037.json","markdown":"https://secwatch.observer/filing/0001193125-24-105037.md","text":"https://secwatch.observer/filing/0001193125-24-105037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703647/000119312524105037/0001193125-24-105037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703647/000119312524105037/d814636d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T14:09:20.104688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}